VIR Jul 2021 50.000 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

13.50

0.00

(0.00%)

As of 03:44PM EDT. Market open.

Loading interactive chart…

GuruFocus.com
Vir Biotechnology Inc (VIR) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Despite a dip in revenue, VIR showcases robust clinical progress and strategic regulatory engagements, underpinned by a strong cash reserve.
Zacks
Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Tops Revenue Estimates
Vir Biotechnology (VIR) delivered earnings and revenue surprises of 51.52% and 250.82%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Business Wire
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
SAN FRANCISCO, May 02, 2024--Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the first quarter ended March 31, 2024.